Association between metabolic syndrome and helicobacter pylori infection diagnosed by histologic status and serological status

Journal of Clinical Gastroenterology

Volumn 46, Issue 10, 2012, Pages 840-845

  Shin, Dong Wook ^a   Kwon, Hyuk Tae ^b   Kang, Jung Min ^a   Park, Jin Ho ^a,b   Choi, Ho Chun ^a   Park, Min Seon ^a   Park, Sang Min ^a   Son, Ki Young ^a   Cho, Belong ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

Author keywords

Helicobacter pylori; histology; metabolic syndrome; serology

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR PARAMETERS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCOME; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; SERODIAGNOSIS; SEX RATIO; SMOKING;

ADULT; ANTIBODIES, BACTERIAL; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONFIDENCE INTERVALS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; ODDS RATIO; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84867711181     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182522477     Document Type: Article

References (45)

1. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437-439.
2. Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97:1675-1679.
3. Danesh J, Youngman L, Clark S, et al. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ. 1999;319:1157-1162.
4. Hoffmeister A, Rothenbacher D, Bode G, et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol. 2001;21:427-432.
5. Ozdem S, Akcam M, Yilmaz A, et al. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest. 2007;30:236-240.
6. Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxinassociated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation. 2002;106: 580-584.
7. Rahman A, Cope MB, Sarker SA, et al. Helicobacter pylori infection and inflammation: implications for pathophysiology of diabetes mellitus and coronary heart disease. J Life Sci. 2009;1:45-50.
8. de Luis DA, Lahera M, Canton R, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care. 1998; 21:1129-1132.
9. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311:711-714.
10. Sung KC, Rhee EJ, Ryu SH, et al. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol. 2005;102:411-417.
11. Takashima T, Adachi K, Kawamura A, et al. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter. 2002;7:86-90.
12. Aslan M, Horoz M, Nazligul Y, et al. Insulin resistance in H. pylori infection and its association with oxidative stress. World J Gastroenterol. 2006;12:6865-6868.
13. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D, et al. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229-238.
14. Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-1222.
15. Gunji T,Matsuhashi N, SatoH, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008;103:3005-3010.
16. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter. 2009;14: 144-150.
17. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation. 1998;98:1286-1290.
18. Ando T, Minami M, Ishiguro K, et al. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther Symp Ser. 2006;2:58-64.
19. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010;103:190-196.
20. Kanbay M, Gur G, Yucel M, et al. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005;50:1228-1231.
21. Migneco A, Ojetti V, Specchia L, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8: 585-589.
22. Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 1998;19:387-394.
23. Corcoran PA, Atherton JC, Kerrigan SW, et al. The effect of different strains of Helicobacter pylori on platelet aggregation. Can J Gastroenterol. 2007;21:367-370.
24. Koenig W, Rothenbacher D, Hoffmeister A, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxinassociated protein A-positive strains and absence of a systemic inflammatory response. Circulation. 1999;100:2326-2331.
25. McDonagh TA, Woodward M, Morrison CE, et al. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J. 1997; 18:1257-1260.
26. Ridker PM, Danesh J, Youngman L, et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men. Ann Intern Med. 2001;135:184-188.
27. Ridker PM, Hennekens CH, Buring JE, et al. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med. 1999; 131:573-577.
28. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation. 2000;101: 1647-1652.
29. Haider AW, Wilson PW, Larson MG, et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol. 2002;40:1408-1413.
30. Strandberg TE, Tilvis RS, Vuoristo M, et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ. 1997;314: 1317-1318.
31. Park SH, Jeon WK, Kim SH, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97:508-513.
32. Loy CT, Irwig LM, Katelaris PH, et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. The Am J Gastroenterol. 1996;91: 1138-1144.
33. Kim SY, Ahn JS, Ha YJ, et al. Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassay. 1998;19:251-270.
34. Park HS. Cut-off values of waist circumference for abdominal obesity among Koreans. J Korean Med Assoc. 2005;48: 1165-1172.
35. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. April 14, 2005. Available at: http://www.idf.org/ metabolic-syndrome. Accessed August 1, 2011.
36. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
37. Luthra GK, DiNuzzo AR, Gourley WK, et al. Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics. Am J Gastroenterol. 1998;93:1291-1296.
38. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-288.
39. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
40. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003; 24:278-301.
41. Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309-316.
42. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999;22:920-924.
43. Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994;40:342-345.
44. Rotimi O, Cairns A, Gray S, et al. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000;53:756-759.
45. Shinchi K, Ishii H, Imanishi K, et al. Relationship of cigarette smoking, alcohol use, and dietary habits with Helicobacter pylori infection in Japanese men. Scand J Gastroenterol. 1997; 32:651-655.